161 related articles for article (PubMed ID: 35999193)
21. New Therapies for Hypophosphatemia-Related to FGF23 Excess.
Athonvarangkul D; Insogna KL
Calcif Tissue Int; 2021 Jan; 108(1):143-157. PubMed ID: 32504139
[TBL] [Abstract][Full Text] [Related]
22. Burosumab treatment in a child with cutaneous skeletal hypophosphatemia syndrome: A case report.
Khadora M; Mughal MZ
Bone Rep; 2021 Dec; 15():101138. PubMed ID: 34660853
[TBL] [Abstract][Full Text] [Related]
23. HRAS-related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects.
Beyens A; Lietaer C; Claes K; De Baere E; Goeteyn M; Lerut B; Syryn H; Vanakker O; Van der Meulen J; Vanwalleghem L; Callewaert B
Clin Genet; 2023 Jun; 103(6):709-713. PubMed ID: 36896710
[TBL] [Abstract][Full Text] [Related]
24. A case report to assess the safety and efficacy of Burosumab, an investigational antibody to FGF23, in a single pediatric patient with Epidermal Nevus Syndrome and associated hypophosphatemic rickets.
Huynh C; Gillis A; Fazendin J; Abdullatif H
Bone Rep; 2022 Dec; 17():101605. PubMed ID: 35899095
[TBL] [Abstract][Full Text] [Related]
25. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
[TBL] [Abstract][Full Text] [Related]
26. Genomic analysis of adult case of ocular surface giant congenital melanocytic nevus and associated clinicopathological findings.
McGrath LA; Palmer JM; Stark A; Glasson W; Warrier SK; Whitehead K; Hamilton H; Brooks K; Johansson PA; Hayward NK
Ophthalmic Genet; 2020 Dec; 41(6):616-620. PubMed ID: 32814477
[TBL] [Abstract][Full Text] [Related]
27. A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanoma.
Nagler A; Vredevoogd DW; Alon M; Cheng PF; Trabish S; Kalaora S; Arafeh R; Goldin V; Levesque MP; Peeper DS; Samuels Y
Pigment Cell Melanoma Res; 2020 Mar; 33(2):334-344. PubMed ID: 31549767
[TBL] [Abstract][Full Text] [Related]
28. Hereditary spastic paraplegia masqueraded by congenital melanocytic nevus syndrome: Dual pathogenesis of germline non-mosaicism and somatic mosaicism.
Sakaguchi Y; Uehara T; Sasaki M; Fujimura K; Kishi K; Kosaki K; Takenouchi T
Eur J Med Genet; 2020 Apr; 63(4):103803. PubMed ID: 31698101
[TBL] [Abstract][Full Text] [Related]
29. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
[TBL] [Abstract][Full Text] [Related]
30. Next-generation sequencing of nevus spilus-type congenital melanocytic nevus: exquisite genotype-phenotype correlation in mosaic RASopathies.
Kinsler VA; Krengel S; Riviere JB; Waelchli R; Chapusot C; Al-Olabi L; Faivre L; Haenssle HA; Weibel L; Jeudy G; Vabres P
J Invest Dermatol; 2014 Oct; 134(10):2658-2660. PubMed ID: 24751729
[No Abstract] [Full Text] [Related]
31. Mosaic NRASopathy n a child with giant melanocytic congenital naevus, epidermal hamartoma and bilateral nephroblastomatosis: clinical implication for follow-up.
Maridet C; Morice-Picard F; Gros A; Crivelli L; de la Fouchardière A; Vergier B; Taïeb A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e258-e260. PubMed ID: 29314428
[No Abstract] [Full Text] [Related]
32. Topical trametinib for epidermal and sebaceous nevi in a child with Schimmelpenning-Feuerstein-Mims syndrome.
Haller CN; Leszczynska MA; Brichta L; Maier E; Riddington IM; Choate KA; Levy ML
Pediatr Dermatol; 2024; 41(3):523-525. PubMed ID: 38273779
[TBL] [Abstract][Full Text] [Related]
33. Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi.
Rouillé T; Aractingi S; Kadlub N; Fraitag S; How-Kit A; Daunay A; Hivelin M; Moguelet P; Picard A; Fontaine RH; Guégan S
J Invest Dermatol; 2019 Sep; 139(9):2004-2015.e13. PubMed ID: 31059696
[TBL] [Abstract][Full Text] [Related]
34. Schimmelpenning-Feuerstein-Mims syndrome with orbital choristoma and
Yeager LB; Casper DS; Del Portillo A; Marr BP
Ophthalmic Genet; 2023 Dec; ():1-6. PubMed ID: 38097938
[TBL] [Abstract][Full Text] [Related]
35. Detection of a multilineage mosaic NRAS mutation c.181C>A (p.Gln61Lys) in an individual with a complex congenital nevus syndrome.
Ulrich M; Tinschert S; Siebert E; Franke I; Tüting T; Ulrich J; Schanze D; Wieland I; Zenker M
Pigment Cell Melanoma Res; 2019 May; 32(3):470-473. PubMed ID: 30548225
[No Abstract] [Full Text] [Related]
36. An update on congenital melanocytic nevus syndrome: A case report and literature review.
Abdulmajid L; Bosisio FM; Brems H; De Vlieger G; Garmyn M; Segers H; Demaerel P; Segers K; Jansen K; Lagae L; Verheecke M
J Cutan Pathol; 2021 Dec; 48(12):1497-1503. PubMed ID: 34255877
[TBL] [Abstract][Full Text] [Related]
37. Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome.
Hoffman WH; Jueppner HW; Deyoung BR; O'dorisio MS; Given KS
Am J Med Genet A; 2005 Apr; 134(3):233-6. PubMed ID: 15742370
[TBL] [Abstract][Full Text] [Related]
38. Epidermal nevus syndrome associated with adnexal tumors, spitz nevus, and hypophosphatemic vitamin D-resistant rickets.
Kishida ES; Muniz Silva MA; da Costa Pereira F; Sanches JA; Sotto MN
Pediatr Dermatol; 2005; 22(1):48-54. PubMed ID: 15660898
[TBL] [Abstract][Full Text] [Related]
39. DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.
de Castro LF; Ovejero D; Boyce AM
Eur J Endocrinol; 2020 May; 182(5):R83-R99. PubMed ID: 32069220
[TBL] [Abstract][Full Text] [Related]
40. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
